查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多重檢測市場：現狀分析與預測（2022-2028 年）
市場調查報告書
商品編碼
1260699

多重檢測市場：現狀分析與預測（2022-2028 年）

Multiplex Assay Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

從 2022 年到 2028 年，多重檢測市場的複合年增長率預計將達到 7% 左右。 多重測定是一種生物測定，可以同時測量一個樣品中的多種分析物（蛋白質、核酸、代謝物等）。 這種技術在生物技術和生物醫學研究中越來越受歡迎，因為它可以同時提供有關多個生物分子的綜合信息。 分子和伴隨診斷領域不斷擴大的研發需求推動了對多重檢測的需求不斷增長，推動了全球主要行業參與者採用有機增長戰略。可以考慮。 例如，針對COVID-19疫情，Thermo Fisher Scientific推出了多重實時PCR診斷試劑盒（TaqPath COVID-19 developed the Multiplex Diagnostic Solution。

根據技術，多重檢測市場細分為多重實時 PCR、流式細胞術等。 多重實時 PCR 部分佔有很大的市場份額，預計在預測期內將快速增長。 PCR 技術廣泛用於各種最終用途。 此外，PCR技術在COVID-19檢測中的廣泛應用，也為這項技術帶來了可觀的收入。

根據應用，市場分為臨床診斷和研發。 研發部門在預測期內獲得了相當大的市場份額。 它在藥物發現過程中的使用正在增加。 這些測試已用於評估臨床前和臨床階段的藥物反應生物標誌物、免疫治療功效和毒性。

為了更好地了解多重檢測的市場採用情況，北美（美國、加拿大、北美其他地區）、歐洲（德國、法國、意大利、西班牙、英國、歐洲其他地區）、亞太地區（中國、日本） )、印度、澳大利亞、亞太其他地區)，以及該地區其他國家/地區的市場佔有率。 由於存在各種研究計劃和積極的研發活動以創造新藥、診斷學和治療學，北美形成了多重分析行業的主要市場。 增加政府對新生物標誌物發現的資助以及癌症和中風等慢性病發病率的增加預計將推動該地區的增長。 此外，該地區主要參與者的存在也可能有助於推動這一增長。

Luminex Corporation、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、QIAGEN N.V.、Becton、Dickinson and Company、Merck KGaA、Seegene Inc、Perkin Elmer Inc、Abcam PLC、Agilent Technologies Inc. 主要參與者誰是 這些公司進行了多項併購和合作。

內容

1 市場介紹

  • 市場定義
  • 主要目的
  • 利益相關者
  • 限制

第 2 章研究方法或假設

  • 研究過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對多重檢測市場的影響

第 6 章多重檢測市場收入，2020-2028F

第 7 章市場洞察：按產品分類

  • 試劑和耗材
  • 儀器和配件
  • 軟件和服務

第 8 章市場洞察：按類型

  • 基於蛋白質的多重分析
  • 基於核酸的多重分析
  • 其他

第 9 章市場洞察：按技術

  • 多重實時 PCR
  • 流式細胞術
  • 其他

第 10 章市場洞察：按應用

  • 臨床診斷
  • 研究與開發

第 11 章市場洞察：最終用戶

  • 製藥和生物技術公司
  • 醫院和診斷實驗室
  • 研究和學術機構
  • 其他

第 12 章市場洞察：按地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 其他亞太地區
  • 世界其他地方

第 13 章多重分析市場動態

  • 市場驅動力
  • 市場挑戰
  • 影響分析

第 14 章多重分析市場機會

第 15 章多重分析市場趨勢

第16章需求側與供給側分析

  • 需求方分析
  • 供應方分析

第 17 章價值鏈分析

第 18 章戰略洞察

第 19 章衝突場景

  • 競爭格局
    • 波特的五力分析

第20章公司簡介

  • Qiagen NV
  • New England Biolabs
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • BGI Genomics Co Ltd
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • Becton Dickinson and Co
  • Bayer AG
  • Agilent Technologies Inc

第21章 免責事項

簡介目錄
Product Code: UMHE211736

The Multiplex Assay Market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Multiplex assay is a type of biological assay that allows simultaneous measurement of multiple analytes (such as proteins, nucleic acids, or metabolites) in a single sample. This technique has gained increasing popularity in the field of biotechnology and biomedical research due to its ability to provide comprehensive information on multiple biomolecules at once. The growing demand for multiplex assay can be attributed to the expanding need for research and development in the fields of molecular diagnostics and companion diagnostics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in response to the COVID-19 outbreak, Thermo Fisher Scientific developed a multiplex real-time PCR diagnostic kit (TaqPath COVID-19 Multiplex Diagnostic Solution) to facilitate public and clinical health laboratories to rapidly diagnose SARS-CoV-2 infection.

Based on the technology, the multiplex assay market is segmented into multiplex real-time PCR, flow cytometry, and others. The multiplex real-time PCR segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR technologies for COVID-19 detection has resulted in significant revenue generation by this technology.

Based on the application, the market is fragmented into clinical diagnostics and research & development. The research & development segment grabbed a considerable market share during the forecast period. Multiplex assays are becoming more and more used in the drug discovery process. These tests are employed in preclinical and clinical phases to assess drug response biomarkers, immunotherapy efficacy, and toxicity.

For a better understanding of the market adoption of multiplex assay, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the multiplex assay industry owing to the presence of various research programs in the region, as well as the expansion of R&D efforts for the creation of new medications and diagnostic and therapeutic approaches. The rise in government financing for the discovery of new biomarkers and the increased frequency of chronic diseases like cancer and stroke are expected to fuel the region's growth. Furthermore, the rise is probably going to be fueled by the presence of important players in the area.

Some of the major players operating in Luminex Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Merck KGaA, Seegene Inc., Perkin Elmer Inc., Abcam PLC, Agilent Technologies Inc. among others. Several M&A's along with partnerships have been undertaken by these players.

TABLE OF CONTENTS

1MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Multiplex Assay Market
  • 2.2. Research Methodology of the Multiplex Assay Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE MULTIPLEX ASSAY MARKET

6 MULTIPLEX ASSAY MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Reagents & Consumables
  • 7.2. Instruments & Accessories
  • 7.3. Software & Services

8 MARKET INSIGHTS BY TYPE

  • 8.1. Protein-Based Multiplex Assay
  • 8.2. Nucleic Acid-Based Multiplex Assay
  • 8.3. Others

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1. Multiplex Real-Time PCR
  • 9.2. Flow Cytometry
  • 9.3. Others

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Clinical Diagnostics
  • 10.2 Research & Development

11 MARKET INSIGHTS BY END-USER

  • 11.1. Pharmaceutical & Biotechnology Companies
  • 11.2. Hospitals & Diagnostic laboratories
  • 11.3. Research & Academic Institutes
  • 11.4. Others

12 MARKET INSIGHTS BY REGION

  • 12.1 NORTH AMERICA
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 EUROPE
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Spain
    • 12.2.5 Italy
    • 12.2.6 Rest of Europe
  • 12.3 ASIA PACIFIC
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.5 Rest of Asia Pacific
  • 12.4 REST OF THE WORLD

13 MULTIPLEX ASSAY MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 MULTIPLEX ASSAY MARKET OPPORTUNITIES

15 MULTIPLEX ASSAY MARKET TRENDS

16 DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1 Demand Side Analysis
  • 16.2 Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1. Competitive Landscape
    • 19.1.1 Porter's Five forces analysis

20 COMPANY PROFILED

  • 20.1. Qiagen NV
  • 20.2. New England Biolabs
  • 20.3. Illumina, Inc.
  • 20.4. Bio-Rad Laboratories, Inc.
  • 20.5. BGI Genomics Co Ltd
  • 20.6. Oxford Nanopore Technologies PLC
  • 20.7. PerkinElmer, Inc.
  • 20.8. Becton Dickinson and Co
  • 20.9. Bayer AG
  • 20.10. Agilent Technologies Inc

21 DISCLAIMER